Skip to content

CBT -I treat insomnia disorders automatic negative emotional response change and neuroimaging studies

CBT -I treat insomnia disorders automatic negative emotional response change and neuroimaging studies

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124291
Enrollment
Unknown
Registered
2026-05-09
Start date
2024-10-31
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia disorder

Interventions

Cbti treatment group.:Conduct Cbti course education
Control group for sleep hygiene education.:Health education
Healthy individual group.:none

Sponsors

The Third Hospital of inner Mongolia Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: CBT-I Treatment Group for Insomnia Disorder 1. Age 18-65 years; 2. Adequate comprehension ability, education level = 9 years; 3. Chinese, right-handed; 4. Patient has signed the informed consent form; 5. Meets the diagnostic criteria for Insomnia Disorder in the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5); 6. ISI > 7, HAMA < 21, HAMD < 24. Control Group for Insomnia Disorder: Inclusion criteria are the same as for the CBT-I treatment group for insomnia disorder. Healthy Group 1. Age 18-65 years; 2. Adequate comprehension ability, education level = 9 years; 3. Chinese, right-handed; 4. Patient has signed the informed consent form; 5. Does not meet the diagnostic criteria for Insomnia Disorder in the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5); 6. Meets the criteria for healthy individuals in SCID-VI.

Exclusion criteria

Exclusion criteria: 1. Exclude individuals with severe dysfunction of the heart, liver, kidneys, and other organs. 2. Exclude those with schizophrenia spectrum and other psychotic disorders, major depressive disorder, bipolar and related disorders, neurocognitive disorders, substance-related and addictive disorders, and other psychiatric disorders caused by physical illnesses or medications. 3. Exclude individuals with other sleep disorders that meet the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria, such as severe sleep apnea syndrome, restless legs syndrome, and periodic limb movement disorder. 4. Exclude pregnant women, women within 6 months postpartum, or women who are lactating. 5. Exclude those who are unable to read and understand the information sheet, informed consent form, or patient self-rating scale. 6. Exclude individuals who have traveled across two time zones or worked night shifts in the past 3 months. 7. Exclude those with a history of brain injury or organic brain diseases. 8. Exclude individuals with contraindications for MRI, including those with metal implants in their bodies or those with claustrophobia.

Design outcomes

Primary

MeasureTime frame
Functional connection;Local activity status;

Secondary

MeasureTime frame
Scoring on the Hamilton Depression Rating Scale;Scoring on the Hamilton Anxiety Rating Scale;Scoring on the Insomnia Severity Index (ISI);Scoring on the Pittsburgh Sleep Quality Index (PSQI);Scoring on the Dysfunctional Beliefs and Attitudes about Sleep Scale-16 (DBAS-16);Scoring on the Hyperarousal Scale;Scoring on the Ford Insomnia Response to Stress Test;Scoring on the Repetitive Neuropsychological Status Test (RNST);polysomnography (PSG);

Countries

China

Contacts

Public ContactPing Yao

The Third Hospital of Inner Mongolia Autonomous Region

wangkecoco00@163.com+86 138 4881 0596

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026